Paul Tudor Jones Dismisses Chances of Fed Rate Cuts Under Potential Chair Warsh Recursion Pharmaceuticals Stock Tumbles to 52Week Low Amid Market Pressures Managing Director Uses Everyday Purchases to Instill Financial Literacy in Children Ferrari Luce EV Launch Sparks Controversy Shares Drop Nearly 8 on Design Criticism SK Hynix Surpasses 1 Trillion Market Cap as AI Demand Drives Chip Stock Surge SpaceXs Starship Test Flight Scrubbed IPO Prospectus Adds Financial Context AIRE Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid PreRevenue Phase CAMT Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises ARMK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Market Reaction MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback Applied Industrial Technologies AIT Q1 2026 Earnings Slight EPS Miss Amid Steady Demand Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations Immatics IMTX Gains Ground Biotech Stock Tests Key Resistance at 1196 Ally Financial ALLY Holds Steady Near Support as Investor Sentiment Remains Cautious BristolMyers Squibb BMY Sees Modest Decline Holds Above Key Support GeneDx Holdings Warrants Rally 1477 From Penny Level Yet Resistance Remains Stubborn Nuveen Municipal Value Fund NUW Advances 104 as Steady Income Appeal Drives Demand SK Hynix and Micron Enter 1 Trillion Club on AI Chip Demand Surge TUSK Q1 2026 Earnings Return to Profitability Drives Shares Higher Smart Logistics Global Limited SLGB Surges 838 Whats Driving the Move SGU Q1 2026 Earnings Strong Earnings Performance Amid Seasonal Peak OKLO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Advanced Nuclear Development CHH Q1 2026 Earnings EPS Misses Street Expectations as Shares Edge Higher EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage MDXG Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges IDCC Q1 2026 Earnings EPS Surges Past Estimates on Strong Licensing Revenue Stock Declines